ATE213623T1 - Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten - Google Patents

Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten

Info

Publication number
ATE213623T1
ATE213623T1 AT95937526T AT95937526T ATE213623T1 AT E213623 T1 ATE213623 T1 AT E213623T1 AT 95937526 T AT95937526 T AT 95937526T AT 95937526 T AT95937526 T AT 95937526T AT E213623 T1 ATE213623 T1 AT E213623T1
Authority
AT
Austria
Prior art keywords
composition
stds
infectant
sexually transmitted
medicinal products
Prior art date
Application number
AT95937526T
Other languages
English (en)
Inventor
William Joseph Bologna
Howard Leslie Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of ATE213623T1 publication Critical patent/ATE213623T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95937526T 1994-10-07 1995-10-06 Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten ATE213623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation
PCT/US1995/013424 WO1996010989A1 (en) 1994-10-07 1995-10-06 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
ATE213623T1 true ATE213623T1 (de) 2002-03-15

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937526T ATE213623T1 (de) 1994-10-07 1995-10-06 Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten

Country Status (24)

Country Link
US (2) US5667492A (de)
EP (1) EP0784466B1 (de)
JP (1) JPH10507178A (de)
KR (1) KR970705976A (de)
AT (1) ATE213623T1 (de)
AU (1) AU704836B2 (de)
BR (1) BR9509280A (de)
CA (1) CA2201872A1 (de)
CO (1) CO4480018A1 (de)
DE (1) DE69525634T2 (de)
DK (1) DK0784466T3 (de)
ES (1) ES2173203T3 (de)
FI (1) FI971440A (de)
HU (1) HUT77527A (de)
IL (1) IL115495A0 (de)
MA (1) MA23687A1 (de)
MX (1) MX9504245A (de)
NO (1) NO971491L (de)
NZ (1) NZ295947A (de)
PE (1) PE46996A1 (de)
PT (1) PT784466E (de)
RU (1) RU2157184C2 (de)
WO (1) WO1996010989A1 (de)
ZA (1) ZA958434B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
EP1356806A1 (de) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited Arzneimittel zur Behandlung von Dysmenorrhöe und verfrühten Wehen
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
CA2335055A1 (en) 1998-06-19 1999-12-23 Jack Fellman Medical device having anti-infective and contraceptive properties
AU4489399A (en) * 1998-06-23 2000-01-10 Notax Holding Gesellschaft M.B.H. Use of nonoxynol-9 as lubricant and method for its production
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
RU2310474C2 (ru) 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
HU230315B1 (hu) 2000-03-07 2016-01-28 Rush-Presbyterian-St. Luke's Medical Center Összetételek és eljárások patogén mikrobák és spermatozoák csapdázására
ES2437846T3 (es) * 2001-02-15 2014-01-14 Access Pharmaceuticals, Inc. Formulaciones líquidas para la prevención y el tratamiento de enfermedades y trastornos de la mucosa
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
PL371945A1 (en) * 2001-10-16 2005-07-11 Avanir Pharmacueticals Viral inhibition by n-docosanol
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
KR20110132482A (ko) 2003-02-07 2011-12-07 얀센 파마슈티카 엔.브이. Ｈｉｖ 감염 예방용 피리미딘 유도체
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN110693812A (zh) * 2012-06-13 2020-01-17 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
US11337989B2 (en) 2013-12-19 2022-05-24 Evofem, Inc. Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
WO2016008039A1 (en) * 2014-07-14 2016-01-21 Novicol International Holding Inc. Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof
CN110225750A (zh) 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE604564A (de) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
EP0077063B1 (de) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon enthaltende Zusammensetzungen und die Anwendung dieser Zusammensetzungen in der Behandlung von Herpesinfektionen, prämalignen Hautverletzungen, Hautmalignitäten und Psoriasis
EP0163696B1 (de) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
ATE112157T1 (de) * 1989-10-31 1994-10-15 Columbia Lab Inc Verfahren zur feuchthaltung von gewebe und mittel dazu.
EP0431719B1 (de) * 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Mittel zur Feuchthaltung vaginalen Gewebes
EP0500807B1 (de) * 1989-10-31 1999-07-07 Columbia Laboratories, Inc. Mittel zur feuchthaltung von gewebe und verfahren
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Also Published As

Publication number Publication date
NZ295947A (en) 1999-02-25
EP0784466A1 (de) 1997-07-23
US5667492A (en) 1997-09-16
FI971440A0 (fi) 1997-04-07
AU3961295A (en) 1996-05-02
NO971491D0 (no) 1997-04-02
PE46996A1 (es) 1996-11-23
ZA958434B (en) 1996-05-08
MA23687A1 (fr) 1996-07-01
KR970705976A (ko) 1997-11-03
NO971491L (no) 1997-06-09
US20010006667A1 (en) 2001-07-05
RU2157184C2 (ru) 2000-10-10
PT784466E (pt) 2002-06-28
AU704836B2 (en) 1999-05-06
JPH10507178A (ja) 1998-07-14
FI971440A (fi) 1997-04-07
DK0784466T3 (da) 2002-04-22
DE69525634D1 (de) 2002-04-04
WO1996010989A1 (en) 1996-04-18
HUT77527A (hu) 1998-05-28
ES2173203T3 (es) 2002-10-16
CA2201872A1 (en) 1996-04-18
CO4480018A1 (es) 1997-07-09
MX9504245A (es) 1997-01-31
DE69525634T2 (de) 2002-08-29
BR9509280A (pt) 1997-11-18
EP0784466B1 (de) 2002-02-27
IL115495A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
ATE213623T1 (de) Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten
EP2459201B1 (de) Hydrogelformulierung mit einem redoxpotential wasser
US3624224A (en) Novel first aid products
JP5972862B2 (ja) 熱ゲル化麻酔組成物
JP3778559B2 (ja) 局所用医薬製剤
CA2111932A1 (en) Quick-Drying Gel-Type Disinfectant for Hands and Fingers
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
BR0008137A (pt) Composição de droga bioadesiva de liberação prolongada e processos para administrar um agente terapêutico e para preparar uma composição de droga bioadesiva de liberação prolongada
US5387611A (en) Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
JPS62234017A (ja) 膣用医薬組成物
BR0213585A (pt) Composição vaginal farmacêutica, e, usos de um agente de tratamento antidisrìtmico e de um carreador bioadesivo de liberação prolongada farmaceuticamente aceitável, e de um agente de tratamento anestésico local e de um carregador bioadesivo de liberação prolongada farmaceuticamente aceitável
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
Jansen et al. Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers
JPH0214059B2 (de)
JP2003300871A (ja) 眼科用組成物
IE45282L (en) Pharmaceutical tablet formulation
IT1254707B (it) Uso topico della calcitonima per la preparazione di medicamenti nella cataratta idiopatica senile e una composizione farmaceutica che la contiene
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee